Video Series

Adam C. Welch, PharmD, MBA, FAPhA, leads a panel discussion surrounding complications related to RSV infection.

A panel of medical experts discuss the prevalence of RSV in adults.

Dr Butrus leads a discussion on the ideal patient population for treating atopic dermatitis with ruxolitinib.

The panelists highlight the treatment nature of ruxolitinib, a JAK inhibitor used to treat atopic dermatitis.

Medical experts provide insights surrounding efforts to ensure equitable health for women across underserved patient populations.

Derek van Amerongen, MD, MS, leads a panel discussion surrounding disparities currently facing women in health care.

Dr Matous leads a conversation regarding CAR T-cell therapy for treating multiple myeloma.

The panel provides an overview of drug treatment options for patients with RRMM.

Managing itch associated with atopic dermatitis is a critical intervention to patient quality of life.

In her closing thoughts, Dr Michos highlights social determinants of health impacting the treatment landscape for patients with cardiovascular disease.

Inclusivity in clinical trials to achieve equitable care.

Derek van Amerongen, MD, MS, drives a panel discussion surrounding disparities currently faced by women in health care.

A panel of multiple myeloma experts discuss costs associated with relapsed/refractory disease.

Treatment considerations for relapsing multiple myeloma is discussed by key opinion leaders.

Brian Keegan, MD, PhD, and Michael Cameron, MD, FAAD, describe treatment options for patients with atopic dermatitis.

Dr Casey Butrus drives a discussion highlighting typical patient presentations of AD.

In their final thoughts, the panelists explore the future of GA treatment strategies.

Dr Khanani discusses how to monitor patients with geographic atrophy for adverse events.

Key opinion leaders discuss clinical and cost considerations for treating patients diagnosed with geographic atrophy.

A medical expert discusses preauthorization requests and requirements for cardiovascular disease treatment, commenting on an abstract presented at the ACC 2023 Annual Scientific Session and Expo and World Congress of Cardiology.

Expert panelists discuss considerations for RRMM treatment strategies.

Jeffrey Matous, MD, leads a panel discussion surrounding the use of bispecifics treatment of relapsed / refractory multiple myeloma.

Key opinion leaders navigate diagnostic challenges associated with atopic dermatitis.

Casey Butrus, PharmD, leads a panel of experts in a discussion surrounding atopic dermatitis.

Dr Lopes provides insights into payer considerations when navigating geographic atrophy treatment pathways.

Drs Lally and Khanani expand on key takeaways from the GATHER1 and GATHER2 studies.

Dr Michos examines a controlled trial focusing on co-payment elimination and its effects on cardiovascular outcomes for low-income adults.

In his closing thoughts, Dr Marshall shares final takeaways from the 2023 ASCO GI Cancers Symposium.